Torrent Pharmaceuticals Limited · Healthcare
$4,768.30
0.0%
Jul 5, 2026
D
WeakGraded against TORNTPHARM's own history at this drawdown — not the market's.
What it means: TORNTPHARM's own history does not strongly favor buying at this level yet.
What to do: Consider watching and waiting for a deeper dip or a higher grade.
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as
Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.
In plain terms: TORNTPHARM is 0% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.
Torrent Pharmaceuticals Ltd. (TORNTPHARM) sits 0.0% off its peak and is currently at or near all-time highs, last printing at $4,768.3. That puts TORNTPHARM in a momentum regime: buyers are in control and there's no meaningful technical damage on the chart yet.
History at this drawdown level is well-populated for TORNTPHARM — 1965 confirmed observations in the 5%-to-0% band. The Dipsern engine uses these to compute a rolling median rather than a mean, because medians are robust to the kind of fat tails you find in indian stocks return distributions. The win rate (% of episodes that closed positive after 90 days) is shown in the segments table below.
Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to TORNTPHARM's own volatility history. At this level the Dipsern signal is mostly tracking momentum, not mean reversion. Most buying-the-dip frameworks aren't relevant when there is no dip.
Five tickers closest to TORNTPHARM's distance from all-time high. Same category, one tap away.
Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for TORNTPHARM. Median forward returns, win rates, and prediction errors are available in the full analysis.
We segment 40+ years of TORNTPHARM's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.
Years of history
40+
Drawdown bands
20
Look-ahead bias
None
Data sources
4
See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for TORNTPHARM.
Dipsern is research and a second opinion — not a broker. You'd buy TORNTPHARM at your own broker.
Analyze TORNTPHARM FreeNo credit card required · 5 free analyses per month
Signal computed Jul 5, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.